Armata Pharmaceuticals (ARMP) Share-based Compensation Growth (3y) (2016 - 2026)
Armata Pharmaceuticals (ARMP) Share-based Compensation Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 244.08% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -50.27% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -0.04% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 38.45% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Armata Pharmaceuticals | 191.29 Mn | 186.49 Mn | - | -76.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76.59% |
| Dec 31, 2025 | -63.43% |
| Sep 30, 2025 | 47.23% |
| Jun 30, 2025 | -15.38% |
| Mar 31, 2025 | 16.57% |
| Dec 31, 2024 | -63.27% |
| Sep 30, 2024 | 12.62% |
| Jun 30, 2024 | 13.75% |
| Mar 31, 2024 | -14.08% |
| Dec 31, 2023 | -39.28% |
| Sep 30, 2023 | -36.84% |
| Jun 30, 2023 | -33.96% |
| Mar 31, 2023 | -6.37% |
| Dec 31, 2022 | 835.61% |
| Sep 30, 2022 | -30.30% |
| Jun 30, 2022 | 9.44% |
| Mar 31, 2022 | 7.22% |
| Dec 31, 2021 | 773.29% |
| Sep 30, 2021 | 288.47% |
| Jun 30, 2021 | 311.68% |